$CURR management ha demonstrated that sales and revenue growth are on an ascending curve as reported for the company's 3rd quarter results. The upcoming year end and then the first quarter results after that should be showing increasing sales momentum based on the growing success of the the products, marketing programs and growing media exposure.

Third Quarter 2022 Results With Strong Sequential and Year Over Year Revenue Increases and Continued High Margins
https://www.accesswire.com/727677/CURE-Pharma...gh-Margins